AMR in the Light of COVID-19

Each of us is now living in a world with a nearly untreatable virus – but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to kill them. COVID-19 foreshadows a grim future if we do not mobilize a global response to the growing threat of antimicrobial resistance (AMR).

Through a four-part series, global experts will discuss how the COVID-19 pandemic could reshape strategies for combating antimicrobial resistance around the world:

1. The global movement of microorganisms: Tracking the spread of difficult-to-treat infections (24 September)
2. Prevention is stronger than a cure (15 October)
3. Aiming in the dark: what happens when disease spreads without diagnosis (5 November)
4. Responding to difficult-to-treat infections: Role and responsibilities of governments, researchers, clinicians, industry and patients (19 November)